PONTES JOSIAS (VP, Head of Finance) received a stock award from SIGILON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/4/2021ACC: 0001415889-21-004690
Officer· VP, Head of Finance
Since Jun 2021
+11.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
11.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.50K
Price / share
—
Trade value
—
% of position
625.3%
9/30/2021
1.84K→13.34K
Total
Net shares
+11.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2021 | A · Award | +11.50K | — | — | 625.3% | 1.84K | 13.34K |
| Total | +11.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported